Yu Yang

Prof. Dr. Yu Yang

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 March 2021 in Cancer Biology & Medicine
Verified
Journal Article
Open access
PDF file
ZZZhen Zhou
Zhen Zhou
ZLZichuan Liu
Zichuan Liu
QOQiuxiang Ou
Qiuxiang Ou
XWXue Wu
Xue Wu
XWXiaonan Wang
Xiaonan Wang
YYYu Yang
Yu Yang
Targeting FGFR in non-small cell lung cancer: implications from the landscape of clinically actionable aberrations of FGFR kinases

2 August 2020 in Journal of Cancer Research and Clinical Oncology
Verified
Journal Article
Closed access
PDF file
FWFeng Wang
Feng Wang
NZNing Zhao
Ning Zhao
GGGe Gao
Ge Gao
HDHong-Bin Deng
Hong-Bin Deng
ZWZhi-Hui Wang
Zhi-Hui Wang
CLCHanglian Lu
CHanglian Lu

4 March 2015 in Cancer Chemotherapy and Pharmacology
Verified
Journal Article
Closed access
PDF file
YYYu Yang
Yu Yang
QZQian Zhao
Qian Zhao
ZWZhou Wang
Zhou Wang
XLXiang-Yan Liu
Xiang-Yan Liu

29 June 2017 in Oncotarget
Verified
Journal Article
Open access
PDF file
JGJincui Gu
Jincui Gu
WZWanchun Zang
Wanchun Zang
BLBing Liu
Bing Liu
LLLei Li
Lei Li
LHLixia Huang
Lixia Huang
YZYanbin Zhou
Yanbin Zhou
Evaluation of digital PCR for detecting low-level EGFR mutations in advanced lung adenocarcinoma patients: a cross-platform comparison study Evaluation of digital PCR for detecting low-level EGFR mutations in advanced lung adenocarcinoma patients: a cross-platform comparison study

12 November 2018 in Cancer Science
Verified
Journal Article
Open access
PDF file
DQDi Qu
Di Qu
FCFeng Cui
Feng Cui
DLDan Lu
Dan Lu
YYYu Yang
Yu Yang
YXYuqing Xu
Yuqing Xu
DEP domain containing 1 (DEPDC1) protein is a novel oncoantigen upregulated in multiple types of cancers which present oncogenic activity and high immunogenicity. However, the function and therapeutic potential of DEPDC1 in hepatocellular carcinoma (HCC) remain unclear. In the present study, we showed that DEPDC1 was frequently upregulated in HCC and associated with cancer diagnosis and poor prognosis for HCC patients. Moreover, DEPDC1 promotes HCC cell proliferation in vitro as well as carcinogenesis in vivo. Notably, DEPDC1 overexpression also increases the neoplasm metastasis ability of HCC cells both in vivo and in vitro. Gene set enrichment analysis results showed that DEPDC1 expression is positively correlated with K‐RAS signal pathway, pathways in cancer and WNT/β‐catenin signal pathway, all of which are closely associated with specific cancer‐related gene sets. Our study provides the basis for further investigation of the molecular mechanism by which DEPDC1 promotes the development and metastasis of HCC.

8 April 2011 in Breast Cancer Research and Treatment
Verified
Journal Article
Closed access
PDF file
YYYu Yang
Yu Yang
RFRennan Feng
Rennan Feng
SBSheng Bi
Sheng Bi
YXYuqing Xu
Yuqing Xu